Retatrutide 70mg*10vials

描述

Core Features
$\ge 99.0\%$ Purity & Ultimate Batch Homogeneity: Produced using industry-leading automated high-throughput solid-phase peptide synthesis (SPPS) technology. Given Retatrutide’s complex heterogeneous peptide chain structure and the substantial 70mg-per-vial dosage, the synthesis presents significant challenges regarding intermediate temperature control and final desalting/purification. We employ precise industrial-grade reversed-phase preparative HPLC (RP-HPLC) to rigorously eliminate by-products such as racemates, truncated chains, and mis-sequences. Each 70mg vial guarantees a baseline purity of $\ge 99.0\%$, providing a clean, interference-free matrix for large-scale in vitro receptor affinity assays and long-term in vivo animal metabolic model studies.
Synergistic Triple-Agonist Mechanism: Retatrutide is a standout molecule in metabolic research, capable of binding with high affinity to three key metabolic receptors: GIPR (glucose-dependent insulinotropic polypeptide receptor), GLP-1R (glucagon-like peptide-1 receptor), and GCGR (glucagon receptor). This unique triple-agonist structure makes it an indispensable tool for investigating mechanisms involving the synergistic downregulation of appetite, delayed gastric emptying, promotion of white adipose tissue browning, and upregulation of overall energy expenditure.
Advanced Cryo-Lyophilization Process: The 70mg high-concentration peptide powder undergoes moisture sublimation at $-80^\circ\text{C}$ in a near-absolute vacuum environment, resulting in a uniform, robust, and collapse-free “lyophilized cake” with a snowflake-like crystalline structure. This process not only ensures excellent reconstitution properties—allowing for rapid dissolution (within seconds) without precipitation or bubble formation when mixed with sterile water for injection or normal saline—but also stabilizes the molecule’s secondary structure. This significantly reduces the risk of thermal degradation and conformational loss during international transit and prolonged customs clearance.

🛠️ Technical Specifications & Parameters
Parameter | Specification Details
Product Specification | 70 mg / Vacuum-Sealed Glass Vial
Molecular Formula | $\text{C}_{211}\text{H}_{342}\text{N}_{54}\text{O}_{68}$
Appearance | White to off-white sterile lyophilized powder / intact solid cake
Validation | Accompanied by original manufacturer HPLC purity chromatograms and MS molecular weight verification reports (one certificate per vial; supports digital traceability and batch verification).

❄️ Storage & Shipping Ironclad Policy
Laboratory Storage Protocol: Upon receipt, the product must be stored immediately in an explosion-proof, research-grade ultra-low temperature freezer ($-20^\circ\text{C}$ to $-80^\circ\text{C}$) while in its unreconstituted state. Maintain conditions that ensure protection from light and moisture, alongside a high-vacuum seal. Storage in standard household appliances or office equipment lacking temperature logging capabilities is strictly prohibited. Given the large 70 mg fill volume and the product’s susceptibility to degradation after reconstitution, researchers are strongly advised to aliquot the sample into single-experiment doses within a laminar flow hood and freeze them; repeated freeze-thaw cycles are strictly prohibited.
Pharmaceutical-Grade Cold Chain Shipping: Strictly adheres to the platform’s “International Shipping and Order Scheduling” protocols. 70mg Retatrutide is shipped using high-density, reinforced five-layer insulated foam boxes combined with high-capacity, factory-grade phase-change gel packs via express delivery. This ensures that the peptide molecule’s complex spatial conformation remains “locked in a frozen state” while traversing diverse global climate zones.

📝 Scientific Compliance & Disclaimer (Research Limitations & Compliance)
⚠️ Strictly for Laboratory Research Use Only (RUO): This product (Retatrutide 70mg) is a chemical reagent intended for cutting-edge life science research. In strict adherence to global biosafety and compliance standards, this product is restricted to academic research within university laboratories, research institutes, or R&D centers of biopharmaceutical companies (e.g., cell receptor binding affinity assays, high-throughput drug screening, long-term metabolic cohort monitoring in large animal models). Any non-compliant use—including human clinical injection, oral administration, substitution for medical prescriptions, or use as an illicit weight-loss agent, performance-enhancing drug, or stimulant—is strictly prohibited. This platform enforces a rigorous multi-stage review process regarding the “End-Use Statement”; any orders suspected of misuse will be unconditionally cancelled and reported to the relevant compliance authorities.